Rheumatology
Research and innovation from the rheumatology experts at Vanderbilt Health

Clues Found in Interval Between Psoriasis and Psoriatic Arthritis
Younger patients and those with severe psoriasis progress more slowly.
Read MoreLatest in Rheumatology

Subtypes of Cells Emerge as Immune System Therapies
Immunophenotyping seeks to identify the ‘problem children’ among immune cells with the goal of precision therapies.

Aggressive, Systemic Vasculitis Now Treated with Avacopan
ADVOCATE study demonstrates power of a game-changing therapy to reduce glucocorticoid use by nearly two-thirds.

High T Cell Totals in Plaques Drive Cardio Risks in Lupus
Immunology and cardiovascular systems interact as inflammatory conditions leading to higher atherosclerosis risk.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.
Make a Referral
Clinic Takes Broad View in Grappling with Long COVID
With questions still outnumbering answers, physicians in a long COVID clinic help patients caught in the pandemic kaleidoscope.

Nutraceutical in Buckwheat Cleans Up RA Inflammation
2-HOBA hunts down the isolevuglandins responsible for proinflammatory cytokines in rheumatoid arthritis.

Three-decade Review Clarifies Pregnancy Risk in Lupus
Researchers find higher risks of adverse events, underutilized options for mitigation.

Non-coding RNA Signals Synovial Joint Reaction
New evidence reveals a critical regulatory role for non-coding RNAs in inflammatory diseases, including rheumatoid arthritis.

Evolving Best Practices in Pediatric Uveitis Treatment
New studies explore advances in standard and immunosuppressive therapies.

Microbial Small RNAs to Predict Arthritis Outcomes
Acting as biomarkers, microbial sRNAs indicate disease severity and drug responses.